Please login to the form below

SEC

This page shows the latest SEC news and features for those working in and with pharma, biotech and healthcare.

Generic threat looms to J&J’s blockbuster Zytiga in US

In a recent Securities &Exchange Commission (SEC) filing, the company said that if a temporary injunction was lifted ahead of the appeals verdict “the company expects that a generic version of

Latest news

Celgene boosts CAR-T stake again with Bluebird Bio deal

with the US Securities and Exchange Commission (SEC), plus royalties on sales.
Theranos and its CEO settle 'massive fraud' charges

SEC says case is a lesson in truth-telling for those seeking to disrupt an industry. ... Jina Choi, director of the SEC’s San Francisco Regional Office, said: “The Theranos story is an important lesson for Silicon Valley.
EU starts investigation of Aspen's cancer drug pricing

This is the first time that the EU authorities have investigated a drugmaker for unjustified price increases, although in the US the Securities &Exchange Commission (SEC) has started an investigation into
Valeant's ex-CEO and CFO 'could face criminal charges'

Valeant is already under scrutiny by the Securities &Exchanges Commission (SEC) in the US as well as US Attorney's Offices in New York and Massachusetts, but was understandably tight-lipped
GSK draws line under Chinese scandal with $20m SEC settlement

In a report, the Securities &Exchange Commission (SEC) said the UK-based drugmaker "from at least 2010 to 2013 … engaged in various transactions and schemes to provide things of value to ... The SEC also said it found that GSK's own control measures on

More from news
Approximately 2 fully matching, plus 53 partially matching documents found.

Latest Intelligence

Creating a successful global compliance programme

The importance of effective compliance programmes was highlighted in the DOJ and SEC’s Resource Guide to the US Foreign Corrupt Practices Act, which describes in detail the hallmarks of a
Deal Watch January 2018

However, in the meantime the US Securities and Exchange Commission (SEC) has issued a lawsuit against some traders for insider trading based on a series of suspicious transactions that made about
US health reforms

In March, the Securities and Exchange Commission (SEC) only narrowly blocked this move.
Deal Watch - May 2017

A good example is Abbott’s acquisition of the diagnostics company Alere signed in February 2016. Two months later Abbott asked Alere to cancel the transaction because of a SEC inquiry ... into accounting issues at Alere and offered $30m to $50m
On the road with the millennial HCP

Yeah I'll put Andy on. Just hang on a sec, he's just sorting our next lift.”.

More from intelligence
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest appointments

RSA announces three new UK hires

In 2009, de Luis moved to the UK with SEC Recruitment and spent three years focussing on the Spanish pharmaceutical market across a number of functional areas.
Scottish cabinet reshuffle sees Alex Neil made health secretary

Commenting on Twitter, Sturgeon said: “It has been a privilege to have been Health Sec[retary] - my thanks to all the wonderful people I have worked with.

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

SALES ACCELERANT

We help companies to engage prim/sec care healthcare professionals more efficiently and effectively to drive sales growth.
SEC Pharma

Analysis, SEC can assist wherever you are looking to hire or work throughout the UK and Europe.